We are live on ! Find out more
LCM

LVM Capital Management Portfolio holdings

AUM $1.19B
1-Year Est. Return 41.5%
This Fund
S&P 500
This Quarter Est. Return
+13.77%
1 Year Est. Return
+41.5%
3 Year Est. Return
+106.81%
5 Year Est. Return
+141.04%
10 Year Est. Return
+1,300.07%
AUM
$750M
AUM Growth
+$86.7M
Cap. Flow
+$3.32M
Cap. Flow %
0.44%
Top 10 Hldgs %
43.61%
Holding
139
New
7
Increased
39
Reduced
54
Closed
4

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$10.9M
2
XOM icon
ExxonMobil
XOM
+$1.28M
3
PFE icon
Pfizer
PFE
+$817K
4
SYK icon
Stryker
SYK
+$799K
5
AMAT icon
Applied Materials
AMAT
+$611K

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$5.82M
2
ATVI
Activision Blizzard
ATVI
+$2.34M
3
LMT icon
Lockheed Martin
LMT
+$1.86M
4
ABBV icon
AbbVie
ABBV
+$1.82M
5
GLD icon
SPDR Gold Trust
GLD
+$1.08M

Sector Composition

Rank Sector Weight
1 Technology 27.91%
2 Healthcare 19.67%
3 Consumer Staples 10.83%
4 Real Estate 7.05%
5 Communication Services 5.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TECH icon
126
Bio-Techne
TECH
$11.2B
$202K 0.03%
+1,560
New +$191K
NSC icon
127
Norfolk Southern
NSC
$76.9B
$200K 0.03%
+672
New +$188K
VO icon
128
Vanguard Morningstar Mid-Cap ETF
VO
$108B
$200K 0.03%
+3,140
New +$197K
WU icon
129
Western Union
WU
$2.23B
$186K 0.02%
10,400
– –
LCTX icon
130
Lineage Cell Therapeutics
LCTX
$282M
$24K ﹤0.01%
10,000
– –
ARTL icon
131
Artelo Biosciences
ARTL
$2.62M
– –
-44
Closed -$9K
CAG icon
132
Conagra Brands
CAG
$7.11B
– –
-20,403
Closed -$691K
TWLO icon
133
Twilio
TWLO
$29.3B
– –
-724
Closed -$231K
CBAY
134
DELISTED
Cymabay Therapeutics
CBAY
– –
-15,000
Closed -$55K
PPCB
135
Propanc Biopharma
PPCB
$3.1M
– –
0
– -$1K
2 3 4 5
6

Similar funds

KOC
Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return
CCM
Condor Capital Management Martinsville, New Jersey $1.2B AUM 13.18% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.4% 1-Year Est. Return
SCM
Sone Capital Management New York $1.19B AUM 14% 1-Year Est. Return
AIM
Anchor Investment Management Columbia, South Carolina $1.2B AUM 17.33% 1-Year Est. Return
MMFA
Main Management Fund Advisors San Francisco, California $1.19B AUM 26.23% 1-Year Est. Return
EC
Elequin Capital New York $1.19B AUM 16.08% 1-Year Est. Return
FCCPG
FountainVest China Capital Partners GP3 Grand Cayman, Cayman Islands $1.2B AUM 6.95% 1-Year Est. Return

LVM Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, LVM Capital Management held 139 positions worth $750M, up 13% from $663M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

LVM Capital Management's Q4 2021 filing shows 7 new, 39 increased, 54 reduced and 4 closed positions. Its largest new stake was Zoetis: 1,416 shares worth $346K. The largest sale was AT&T, an estimated $5.82M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Staples.

  • LVM Capital Management's largest Q4 2021 buy was Zoetis: 1,416 shares worth $346K.
  • LVM Capital Management added most to Medtronic in Q4 2021, an estimated $10.9M increase.
  • LVM Capital Management's biggest Q4 2021 reduction was AT&T, cutting an estimated $5.82M.
  • LVM Capital Management fully exited Conagra Brands in Q4 2021, selling an estimated $691K.
  • LVM Capital Management's ten largest holdings make up 44% of its $750M portfolio in Q4 2021.
  • LVM Capital Management opened 7 new positions and closed 4 in Q4 2021.
  • LVM Capital Management's portfolio value rose 13% quarter-over-quarter to $750M.

Based on LVM Capital Management's 13F filing for Q4 2021, filed 4 Jan 2022.